Related Experiment Video
Updated: Apr 23, 2026
07:51
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
1.3K
Medical Marijuana programs: implications for cannabis control policy--observations from Canada
Benedikt Fischer1, Sharan Kuganesan2, Robin Room3
1Centre for Applied Research in Mental Health and Addiction, Faculty of Health Sciences, Simon Fraser University, 2400 - 515 West Hastings St., Vancouver, Canada V6B 5K3; Social & Epidemiological Research Department, Centre for Addiction and Mental Health, 33 Russell St., Toronto, Canada M5S 2S1; Department of Psychiatry, University of Toronto, 250 College St., Toronto, Canada M5T 1R8.
The International Journal on Drug Policy
|October 8, 2014
Summary
Canada
Area of Science:
- Public Health
- Drug Policy
- Cannabis Research
Background:
- Global trend towards cannabis control reform, including decriminalization and legalization.
- Canada maintains prohibition despite high cannabis use rates.
- Previous medical marijuana program faced criticism for complexity and low uptake.
Purpose of the Study:
- To analyze Canada's evolving medical cannabis regulations.
- To assess if these changes represent a "sneaky side door" or a "better third way" to cannabis control reform.
- To explore the wider implications of these developments in cannabis policy.
Main Methods:
- Analysis of Canada's 'marijuana for medical purposes regulations'.
- Comparison with international medical cannabis schemes (e.g., California).
- Discussion of potential impacts on cannabis control and public health.
Main Results:
- New regulations allow physician authorization for medical marijuana for various conditions.
- Supply is now facilitated by licensed commercial producers.
- Significant increase in expected users and producers, suggesting de facto legalization.
Conclusions:
- Canada's new medical cannabis framework may function as a de facto legalization.
- The evolving regulations offer a potential pathway for cannabis control reform.
- Further implications for public health and drug policy require ongoing evaluation.
Related Concept Videos
01:03Drug Control Governance: Regulatory Bodies and Their Impact
688
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
688
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.4K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.4K
01:25Drug Regulation
2.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.9K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
1.1K
01:27Hallucinogens and Psychedelics
1.0K
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
1.0K
01:29Therapeutic Drug Monitoring: Affecting Factors
420
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
420